Terapevticheskii arkhivTerapevticheskii arkhiv0040-36602309-5342LLC Obyedinennaya Redaktsiya29712Lengthening of Q-Tinterval in isoniazid treatment (case report and review of literature)MakarovL M-ChuprovaS N-GaripovR Sh-SorokinaE V-PolyakovaE В-KalininL A-151220037812545809042020Copyright © 2003, Consilium Medicum2003clinical notestuberculosistreatmentisoniazideelectrocardiogramзаметки из практикитуберкулезлечениеизониазидэлектрокардиограмма[Dessertene F. La tachycardie ventriculaire a deux foyers opposes variables. Arch. Mai. Coeur 1966; 59: 263-272.][Locati E. Torsades de pointes. In: Moss A., Stern S. eds. Noninvasive electrocardiology. Clinical aspects of Holter monitor ing. Saunders Co; University Press, Cambridge, UK; 1997. 59-73.][Selzer A., Wray H. Quinidine syncope. Paroxysmal ventricular fibrillation occuring during treatment of chronic atrial arrhythmias. Circulation 1964; 30: 17-26.][Макаров Л. М. Холтеровское мониторирование. М.: Медпрактика; 2000.][Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of Q- T interval and sudden death. Am. Heart J. 1957; 54: 59-68.][Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell' eta pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossistica. (Presentazione del primo caso della letteratura pediatrica Italiana.). Clin. Pediatr. 1963; 45: 656-683.][Ward О. С A new familial cardiac syndrome in children. J. Irish Med. Assoc. 1964; 54: 103-106.][Pagano L., Delia Monica R., Malinconico M. Proarrhythmia due to the amiodarone. Minerva Cardioangiol. 2001; 49 (6): 421-428.][Glassman A. #., Bigger J. T. Jr. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am. J. Psychiatry 2001; 158 (11): 1774-1782.][Meuleman C., Jourdain P., Bellorini M. et al. Citalopram and Torsades de Pointes. A case report. Arch. Mai. Coeur 2001; 94 (9): 1021-1024.][Roden D. M. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc, Res. 2001; 50 (20): 224-231.][Drici M. D., Clement N. Is gender a risk factor adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf. 2001; 24 (80): 575-585.][Diaz-Peromingo J. A., Marino-Callejo A. I., Gonzalez-Gonzalez С et al. Tuberculous myocarditis presenting as long QT syndrome. Eur. J. Int. Med. 2000; 11 (6): 340-342.][Chan A. C, Dickens P. Tuberculous myocarditis presenting as sudden cardiac death. Forens. Sci. Int. 1992; 57 (1): 45-50.][Hassan D. N., Hanna A. J. Tuberculosis and sudden death in Baghdad. Am. J. Forens. Med. Pathol. 1984; 5 (2): 169-174.][Chapman R. C, Claydon S. M. Mycobacterium tuberculosis: a continuing cause of sudden and unexpected death in west Lon-don. J. Clin. Pathol. 1992; 45 (8): 713-715.][Alkhuja S., Miller A. Tuberculosis and sudde death: a case report and review. Heart and Lung 2001; 30 (5): 388-391.][Справочник Видаль. Лекарственные препараты в России: Справочник. М.: АстраФармСервис; 1999.][Roy M., Dumaine R., Brown A. HERG a primary human ventricylar target of the nonsedating antihitamine terfanadine. Circulation 1996; 94: 817-823.][Mitcheson J., Chen J., Lin M. et al. A structural basis for druginduced long QT syndrome. Proc. Natl. Acad. Sci. USA. 2000; 97 (22): 12329-12333.][Sesti F.. Abbott G., Wei J. et al. A common polymorphism as sociated with antibiotic-induced cardiac arrhythmia. Ibid. (19): 10613-10618.][Лоуренс Д., Беннит П. Клиническая фармакология: Пер. англ. М.: Медицина; 1993; т. 1.][Лильин Е. Т., Трубников В. И., Ванюков М. М. Введение в современную фармакогенетику. М.: Медицина; 1984.]